Morphology of a GHRH producing pancreatic islet cell tumour causing acromegaly
- PMID: 3016979
- DOI: 10.1007/BF00705425
Morphology of a GHRH producing pancreatic islet cell tumour causing acromegaly
Abstract
A 54 year old woman suffered from acromegaly due to a pancreatic islet cell tumour producing GHRH. The tumour was demonstrated on CT scan. The diagnosis was established from elevated plasma levels of GHRH, GH and prolactin, and by the lack of signs of a pituitary adenoma in trans-sphenoidal surgery. Acromegaly was cured by tumour removal. Light microscopically, the tumour showed a medullary and microlobular pattern. The cells were large and often cuspidal. Small granules were found in semi-thin sections. Small aggregations of amyloid fibres were seen, mostly around capillaries. Immunocytochemistry revealed GHRH, NSE, neurotensin, serotonin, VIP and PP. S 100 was positive only in nerve fibres. Staining for GH, ACTH, calcitonin, alpha-HCG, beta-HCG, insulin, glucagon, gastrin, substance P, bombesin and somatostatin was negative. Ultrastructure showed oval partly lobulated nuclei with small nucleoli, moderate amounts of rough endoplasmic reticulum, many free ribosomes, some large Golgi fields and small numbers of secretory granules measuring 150 nm or, in a few cells, 650 nm. Only 4 other cases of pancreatic endocrine tumours causing acromegaly by ectopic GHRH secretion are described in the literature and these were similar to our case in many respects.
Similar articles
-
A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly.J Clin Endocrinol Metab. 1997 Aug;82(8):2731-7. doi: 10.1210/jcem.82.8.4175. J Clin Endocrinol Metab. 1997. PMID: 9253362
-
Acromegaly and Zollinger-Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone-releasing factor.J Clin Endocrinol Metab. 1984 Nov;59(5):1002-5. doi: 10.1210/jcem-59-5-1002. J Clin Endocrinol Metab. 1984. PMID: 6090497
-
Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor.Acta Endocrinol (Copenh). 1986 Sep;113(1):23-8. doi: 10.1530/acta.0.1130023. Acta Endocrinol (Copenh). 1986. PMID: 2876570
-
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.Pituitary. 2006;9(3):221-9. doi: 10.1007/s11102-006-0267-0. Pituitary. 2006. PMID: 17036195 Review.
-
Ectopic acromegaly.Endocrinol Metab Clin North Am. 1992 Sep;21(3):575-95. Endocrinol Metab Clin North Am. 1992. PMID: 1521513 Review.
Cited by
-
Growth hormone-releasing hormone (GRH)-producing pancreatic tumor with no evidence of multiple endocrine neoplasia type 1.Dig Dis Sci. 1997 Jul;42(7):1480-5. doi: 10.1023/a:1018818811199. Dig Dis Sci. 1997. PMID: 9246050
-
Multiple endocrine neoplasia type 1 (MEN 1) revisited.Virchows Arch. 1995;426(6):541-8. doi: 10.1007/BF00192107. Virchows Arch. 1995. PMID: 7655733 Review.
-
Combined sellar gangliocytoma and pituitary adenoma in acromegaly or Cushing's disease. A report of 3 cases.Virchows Arch. 1994;425(1):93-9. doi: 10.1007/BF00193956. Virchows Arch. 1994. PMID: 7921420 Review.
-
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.Pancreas. 2010 Aug;39(6):735-52. doi: 10.1097/MPA.0b013e3181ebb168. Pancreas. 2010. PMID: 20664472 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous